243 related articles for article (PubMed ID: 16423381)
1. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
[TBL] [Abstract][Full Text] [Related]
2. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
[TBL] [Abstract][Full Text] [Related]
3. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
[TBL] [Abstract][Full Text] [Related]
4. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells.
Mylonas I; Jeschke U; Winkler L; Makovitzky J; Richter DU; Briese V; Friese K
Arch Gynecol Obstet; 2003 Aug; 268(3):142-50. PubMed ID: 12883824
[TBL] [Abstract][Full Text] [Related]
7. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K
Gynecol Oncol; 2004 Apr; 93(1):92-7. PubMed ID: 15047219
[TBL] [Abstract][Full Text] [Related]
8. Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.
Vogl J; Höing A; Schulze S; Kuhn C; Wiest I; Shabani N; Jeschke U; Mylonas I; Friese K
Anticancer Res; 2007; 27(4A):1989-93. PubMed ID: 17649810
[TBL] [Abstract][Full Text] [Related]
9. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
Mylonas I
Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
[TBL] [Abstract][Full Text] [Related]
10. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
[TBL] [Abstract][Full Text] [Related]
11. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
Burges A; Shabani N; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
[TBL] [Abstract][Full Text] [Related]
12. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
[TBL] [Abstract][Full Text] [Related]
13. Beta A versus beta B: is it merely a matter of expression?
Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
[TBL] [Abstract][Full Text] [Related]
14. Inhibin/activin-betaC and -betaE subunits in the Ishikawa human endometrial adenocarcinoma cell line.
Kimmich T; Brüning A; Käufl SD; Makovitzky J; Kuhn C; Jeschke U; Friese K; Mylonas I
Arch Gynecol Obstet; 2010 Aug; 282(2):185-91. PubMed ID: 20012305
[TBL] [Abstract][Full Text] [Related]
15. Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle.
Mylonas I; Jeschke U; Wiest I; Hoeing A; Vogl J; Shabani N; Kuhn C; Schulze S; Kupka MS; Friese K
Histochem Cell Biol; 2004 Nov; 122(5):461-71. PubMed ID: 15480736
[TBL] [Abstract][Full Text] [Related]
16. Inhibin-βA subunit immunolabeling as a prognostic factor in endometrioid adenocarcinomas: a matter of evaluation?
Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):467-76. PubMed ID: 20865419
[TBL] [Abstract][Full Text] [Related]
17. Activin-A secretion is increased in the eutopic endometrium from women with endometriosis.
Rombauts L; Donoghue J; Cann L; Jones RL; Healy DL
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):148-53. PubMed ID: 16638039
[TBL] [Abstract][Full Text] [Related]
18. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
19. Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
Mylonas I; Worbs S; Shabani N; Kuhn C; Kunze S; Schulze S; Dian D; Gingelmaier A; Schindlbeck C; Brüning A; Sommer H; Jeschke U; Friese K
Eur J Cancer; 2009 May; 45(7):1304-1314. PubMed ID: 19231155
[TBL] [Abstract][Full Text] [Related]
20. Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry.
Hofland J; van Nederveen FH; Timmerman MA; Korpershoek E; de Herder WW; Lenders JW; Verhofstad AA; de Krijger RR; de Jong FH
Clin Endocrinol (Oxf); 2007 Mar; 66(3):335-40. PubMed ID: 17302865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
